what diffuse large b-cell lymphoma patients should receive therapy different from r-chop?
Published 6 years ago • 14K plays • Length 26:29Download video MP4
Download video MP3
Similar videos
-
23:21
who should receive treatment with something beyond r-chop for aggressive lymphoma?
-
15:16
debate: how should patients with abc type dlbcl be treated today? - r-chop
-
8:21
diffuse large b-cell lymphoma (dlbcl) - aggressive b-cell neoplasm - non-hodgkin’s lymphoma
-
16:21
should r-chop remain the standard of care for dlbcl?
-
24:24
double-hit dlbcl
-
20:48
current upfront management of dlbcl
-
15:17
what is the best therapy for primary mediastinal diffuse large b-cell lymphoma
-
12:40
debate: a case of stage iv follicular lymphoma - r-chop or b-r
-
10:09
understanding diffuse large b-cell lymphoma with jennifer amengual, md
-
18:50
maintenance therapy: is it of value in advanced diffuse large b-cell lymphoma?
-
7:23
diffuse large b-cell lymphoma (dlbcl) regimens
-
23:58
double hit lymphoma - what is it and how should we treat it?
-
3:59
current research on diffuse large b-cell lymphoma (dlbcl)
-
6:42
diffuse large b-cell lymphoma - diagnosis& treatment - aggressive b-cell non-hodgkin’s lymphoma
-
1:08
cc122: a new imid in the treatment of diffuse large b-cell lymphoma
-
20:02
what are the hurdles to using cell of origin in classification to treat dlbcl?
-
9:30
debate: should dlbcl patients be treated differently based on cell of origin? - no
-
3:04
pet-directed therapy for early-stage diffuse large b-cell lymphoma
-
2:13
phase ii trial of split-dose r-chop for older patients with dlbcl